|
Re: Events section update...
|
4
|
Resverlogix Corp.
|
Jun 29, 2016 11:40AM
|
|
Re: Excellent Discussion
|
2
|
Resverlogix Corp.
|
Jul 28, 2017 10:59AM
|
|
Re: Exempt Distribution on SEDAR
|
2
|
Resverlogix Corp.
|
Apr 21, 2017 04:21PM
|
|
Re: Exempt Distribution on SEDAR
|
|
Resverlogix Corp.
|
Apr 21, 2017 04:45PM
|
|
Re: Explanation of difference between Endcrinology and CVD
|
7
|
Resverlogix Corp.
|
Oct 05, 2015 10:41AM
|
|
Re: Explanation?
|
3
|
Resverlogix Corp.
|
Oct 05, 2017 01:48PM
|
|
Re: Exposure in Motley Fool....
|
4
|
Resverlogix Corp.
|
Oct 09, 2019 01:51PM
|
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 10:39AM
|
|
Re: Exposure in Motley Fool....
|
3
|
Resverlogix Corp.
|
Oct 08, 2019 10:40AM
|
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 11:05PM
|
|
Re: Extended Betonmace trial
|
3
|
Resverlogix Corp.
|
Apr 20, 2017 05:28PM
|
|
Re: FA
|
12
|
Resverlogix Corp.
|
May 15, 2018 02:47PM
|
|
Re: FA
|
3
|
Resverlogix Corp.
|
Oct 02, 2017 03:56PM
|
|
Re: FA
|
2
|
Resverlogix Corp.
|
Sep 19, 2017 04:13PM
|
|
Re: FA and FDA
|
6
|
Resverlogix Corp.
|
Jun 28, 2017 02:37PM
|
|
Re: FA expectations
|
5
|
Resverlogix Corp.
|
Sep 19, 2017 05:09PM
|
|
Re: Fabry trial news, Halifax and Alberta's Children't Hospital slated....
|
5
|
Resverlogix Corp.
|
Oct 28, 2017 02:38PM
|
|
Re: Fabry trial news, Halifax and Alberta's Children't Hospital slated....
|
4
|
Resverlogix Corp.
|
Jun 14, 2017 10:44AM
|
|
Re: fda
|
5
|
Resverlogix Corp.
|
Nov 03, 2015 12:52PM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
5
|
Resverlogix Corp.
|
Jun 14, 2016 07:21AM
|
